MDM2 expression in EBV-infected nasopharyngeal carcinoma cells. - Wikidata - wikimedia - TriplyDB

MDM2 expression in EBV-infected nasopharyngeal carcinoma cells.

MDM2 expression in EBV-infected nasopharyngeal carcinoma cells.

http://www.wikidata.org/entity/Q40510932

about

Chromosomal imbalances in nasopharyngeal carcinoma: a meta-analysis of comparative genomic hybridization results Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals.TSGΔ154-1054 splice variant increases TSG101 oncogenicity by inhibiting its E3-ligase-mediated proteasomal degradation.Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation.NOLC1, an enhancer of nasopharyngeal carcinoma progression, is essential for TP53 to regulate MDM2 expression.Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma.The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers.Role of the MDM2 SNP309 polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma

P2860

Q25255613-47F6152F-302A-486F-A622-969D02796E41 Q34611577-7E5D64E5-28AA-4C69-99B4-1C85BE7B96BE Q36664052-B50E21DD-42DB-42E3-A3A0-51DA0963B44F Q36946765-92CA6D97-548D-412F-86CE-D7AB52B75695 Q36972803-F3A694B1-DFED-4CD1-9FB0-32D244BE1DED Q37123246-DEB3402C-F24A-4C60-905F-B5071D408EAC Q37257200-3105FC19-7FEA-482E-A41F-9EE293F60F58 Q37575613-6C55BC0B-FC23-4479-837F-E02498DE6DBE Q38264787-8AE5975A-392B-47AC-A8ED-0877CE59E41C Q42096715-6FA30234-6E64-4707-95AD-44D646959B84 Q58835460-578740FF-958B-4ED5-ADCF-B6C351354E87

P2860

MDM2 expression in EBV-infected nasopharyngeal carcinoma cells.

http://www.wikidata.org/entity/Q40510932

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

MDM2 expression in EBV-infected nasopharyngeal carcinoma cells.

@en

type

label

MDM2 expression in EBV-infected nasopharyngeal carcinoma cells.

@en

prefLabel

MDM2 expression in EBV-infected nasopharyngeal carcinoma cells.

@en

P1433

Q40510932-2D55C8FD-6EE5-4744-BCCD-F02B635BE93A

P1476

Q40510932-2BE06EE5-F0FF-433F-9CD7-AA81F997F783

P2093

Q40510932-0BD12147-A8DB-490E-9E70-90267CFAC5B3

Q40510932-57693A1E-62AF-4295-9BE6-A702AEE5E6EA

Q40510932-6F623723-A45C-47D4-BADA-7F0BBF6E5424

Q40510932-A68F5490-3DFC-4649-9A9B-DF6143F7DD47

Q40510932-DA033B93-38D4-47C0-B9CA-571928DEA133

Q40510932-DD52FA66-1273-4B01-A5B3-5599F55B7D8F

Q40510932-E1638748-FB66-4D12-80F8-86276168EE53

P2860

Q40510932-00473417-B135-4D5A-81D4-5EC3DE3DB3FD

Q40510932-01D5DCFA-872E-4E9B-AC1E-17AFD1376C20

Q40510932-07464759-9E5A-45D5-9A6C-D22B13A5DC24

Q40510932-292BA141-FC97-43F9-9783-17CB45F18B93

Q40510932-38AB81EC-4D4C-4146-9C1F-DEAC67A1C119

Q40510932-3E27B09C-BC87-4ECF-A456-89214C8004E8

Q40510932-4A5EFCBC-93F2-4CE1-B378-A37DAAF6CACF

Q40510932-98940AD9-8B03-4758-B5E4-EC0A01848114

Q40510932-A459F6D1-D9F9-465C-B76A-E06F4C6BDC38

Q40510932-AA40871A-2755-47C6-B8C1-EDC241E543DC

P2888

Q40510932-A60525F9-87AB-469D-AA5D-67FD16874EE0

P304

Q40510932-5E258CEB-2EA6-47CE-8932-05545ADC9706

P31

Q40510932-50094AA0-F4B3-49C6-A3E4-1A3815D04E4B

P356

Q40510932-3A6BF8EB-50C3-4EE5-B965-7120518AB204

P433

Q40510932-F4D2F199-B7F7-43AA-9715-CCE0E627F284

P478

Q40510932-706D2449-41FF-4A02-86A7-6C8895B0A275

P577

Q40510932-BE1EEBA7-52A1-4072-96EE-75BC956E8247

P5875

Q40510932-8C0FED47-7268-41D0-8462-676213DE66FC

P6179

Q40510932-CEA2EBEE-B4A6-43C2-A6C6-5273A64BDF7D

P698

Q40510932-072A4ABE-98EA-45AF-829A-3744FBB2F493

P356

LABINVEST.3700183

P1433

Laboratory Investigation

P1476

MDM2 expression in EBV-infected nasopharyngeal carcinoma cells.

@en

P2093

Chin-Tarng Lin

http://www.w3.org/2001/XMLSchema#string

Chung-Kwe Wang

http://www.w3.org/2001/XMLSchema#string

Han-Chung Wu

http://www.w3.org/2001/XMLSchema#string

Jen-Kuo Hwang

http://www.w3.org/2001/XMLSchema#string

Jeng-Jie Lee

http://www.w3.org/2001/XMLSchema#string

Tung-Ying Lu

http://www.w3.org/2001/XMLSchema#string

Yu-Ju Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction between the retinoblastoma protein and the oncoprotein MDM2

MDM2--master regulator of the p53 tumor suppressor protein

Suspected nasopharyngeal carcinoma in three workers with long-term exposure to sulphuric acid vapour

Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.

Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.

An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma.

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.

HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.

Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

P2888

labinvest.3700183

P304

1547-1556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LABINVEST.3700183

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8265996

http://www.w3.org/2001/XMLSchema#string

P6179

1026934232

http://www.w3.org/2001/XMLSchema#string

P698

15448710

http://www.w3.org/2001/XMLSchema#string